NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.
Colossal Biosciences
9 followers
Calico
8 followers
Vaxcyte
5 followers
Watchmaker Genomics
5 followers
Discovery Life Sciences
3 followers
Mineralys Therapeutics
3 followers
Enveda Biosciences
2 followers
Immunome
2 followers
Foresight Diagnostics
2 followers
ZBiotics
2 followers
Cogent Biosciences
1 follower
Celcuity
1 follower